Ads
related to: pancreatic cancer, cancer treatment- Dosing & Administration
Find Important Dosing, Modification
& Administration Info for Providers
- Contact a Specialist
HCPs: Get In Touch with an Oncology
Account Specialist for More Info
- Clinical Efficacy, Safety
See Efficacy Results & Study Info
for This Treatment Option
- Resources For Oncologists
Download Dosing Guide, Watch Videos
and More for Providers
- Read The Patient Brochure
Help Patients Take An Active Role
During Treatment. Download & Share.
- Important Safety Info
Read important safety information
About this treatment
- Dosing & Administration
Search results
Biotech Advances Propel Oncology Market to $564.5B Amid Youth Cancer Spike
Morningstar· 4 days agoUSA News Group News Commentary – The potential threat of cancer looms for everyone, but now new studies are revealing an increased number of cancer cases ...
Oncolytics doses first subject in pancreatic cancer trial
Clinical Trials Arena via Yahoo Finance· 4 days agoOncolytics Biotech has dosed the first patient with a combination therapy of pelareorep and modified...
Newswise Expert | Diane Simeone, UC San Diego Health
Newswise· 6 days agoSimeone partners with academic and clinical leaders to guide cancer research and care and provides counsel to campus and university-level committees. Prior to her current ...
EU Adds CAR-T Warning; New Blincyto Indication; Good News in Pancreatic Cancer
MedPage Today· 4 days agoAstraZeneca announced that a phase III trial of capivasertib (Truqap) plus paclitaxel failed to...
In vitro photothermal therapy of pancreatic cancer mediated by immunoglobulin G-functionalized...
Nature· 3 days agoPancreatic cancer is one of the most aggressive forms of cancer, and treatment options are limited. One therapeutic ...
Innovent Reports Oncology Pipeline Updates at Investor Meeting
Tehachapi News· 6 days agoAt several major international oncology annual meetings this year, Innovent presented clinical data on multiple cancer drug candidates, including 10 oral reports and over ...
Anti-inflammatory drug celecoxib could reduce risk of colon cancer recurrence for a subset of...
Medical Xpress· 6 days agoThe results are published in the Journal of Clinical Oncology. "These findings strengthen a growing...
Alex Trebek honored with postage stamp
The Hill via Yahoo News· 10 hours agoThe late “Jeopardy!” host Alex Trebek will be honored with a U.S. postage stamp that will be available beginning next month. The U.S. Postal Service...
iOnctura raises nearly $86m in Series B to fund Phase II cancer trials
Clinical Trials Arena via Yahoo Finance· 4 days agoThe therapy’s safety and pharmacokinetics are being evaluated in a Phase I/II study (NCT05586516) in...
Anti-inflammatory drug celecoxib could reduce risk | Newswise
Newswise· 7 days agoBoston – An analysis of data from a randomized clinical trial for patients with stage 3 colon cancer...
Ads
related to: pancreatic cancer, cancer treatment
